These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16148097)

  • 1. Influence of xenogeneic beta2-microglobulin on functional recognition of H-2Kb by the NK cell inhibitory receptor Ly49C.
    Benoit LA; Shannon J; Chamberlain JW; Miller RG
    J Immunol; 2005 Sep; 175(6):3542-53. PubMed ID: 16148097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A species-specific determinant on beta2-microglobulin required for Ly49A recognition of its MHC class I ligand.
    Mitsuki M; Matsumoto N; Yamamoto K
    Int Immunol; 2004 Feb; 16(2):197-204. PubMed ID: 14734604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenogeneic beta 2-microglobulin substitution alters NK cell function.
    Benoît LA; Tan R
    J Immunol; 2007 Aug; 179(3):1466-74. PubMed ID: 17641012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells.
    Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG
    J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
    Michaëlsson J; Achour A; Rölle A; Kärre K
    J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.
    Sullivan LC; Berry R; Sosnin N; Widjaja JM; Deuss FA; Balaji GR; LaGruta NL; Mirams M; Trapani JA; Rossjohn J; Brooks AG; Andrews DM
    J Biol Chem; 2016 Sep; 291(36):18740-52. PubMed ID: 27385590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex genes determine natural killer cell tolerance.
    Dorfman JR; Raulet DH
    Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
    Orihuela M; Margulies DH; Yokoyama WM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11792-7. PubMed ID: 8876216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of H-2K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function.
    Tai LH; Goulet ML; Belanger S; Troke AD; St-Laurent AG; Mesci A; Toyama-Sorimachi N; Carlyle JR; Makrigiannis AP
    Mol Immunol; 2007 Apr; 44(10):2638-46. PubMed ID: 17240452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro.
    Kambayashi T; Michaëlsson J; Fahlén L; Chambers BJ; Sentman CL; Kärre K; Ljunggren HG
    Eur J Immunol; 2001 Mar; 31(3):869-75. PubMed ID: 11241292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
    Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
    J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
    Matsumoto N; Mitsuki M; Tajima K; Yokoyama WM; Yamamoto K
    J Exp Med; 2001 Jan; 193(2):147-58. PubMed ID: 11148219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove.
    Matsumoto N; Yokoyama WM; Kojima S; Yamamoto K
    J Immunol; 2001 Apr; 166(7):4422-8. PubMed ID: 11254697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
    Routes JM; Ryan JC; Ryan S; Nakamura M
    Int Immunol; 2001 Oct; 13(10):1301-7. PubMed ID: 11581175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Qa-1(b)-binding receptors in the specificity of developing NK cells.
    Salcedo M; Colucci F; Dyson PJ; Cotterill LA; Lemonnier FA; Kourilsky P; Di Santo JP; Ljunggren HG; Abastado JP
    Eur J Immunol; 2000 Apr; 30(4):1094-101. PubMed ID: 10760798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetramer.
    Matsumoto N; Tajima K; Mitsuki M; Yamamoto K
    Int Immunol; 2001 May; 13(5):615-23. PubMed ID: 11312249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.